COVID-19, infection fatality rate (IFR) implied by the serology, antibody, testing in New York City
Author:
Open Access
- 1 March 2026
- journal article
- Published by KEAI Publishing in Infectious Disease Modelling
- Vol. 11 (1) , 303-309
Abstract
This paper estimates COVID-19 infection fatality rate (IFR) in early 2020 before pharmaceutical interventions were available on a large population in the United States. The better estimates of COVID-19 deaths in New York City and its high COVID-19 infection rate made it ideal to accurately estimate the IFR. Further, we analyze the deaths and infections in New York City to estimate an overall IFR for the United States of 0.86 percent.Keywords
This publication has 14 references indexed in Scilit:
- Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysisThe Lancet, 2022
- ESTIMATING THE VALUE OF STATISTICAL LIFE (VSL) LOSSES FROM COVID-19 INFECTIONS IN THE UNITED STATESGlobal Journal of Business Disciplines, 2022
- The Macroeconomics of EpidemicsThe Review of Financial Studies, 2021
- COVID-19 antibody seroprevalence in Santa Clara County, CaliforniaInternational Journal of Epidemiology, 2021
- Spread of SARS-CoV-2 in the Icelandic PopulationNew England Journal of Medicine, 2020
- Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 PandemicJACC, 2020
- Estimates of the severity of coronavirus disease 2019: a model-based analysisThe Lancet Infectious Diseases, 2020
- Universal Screening for SARS-CoV-2 in Women Admitted for DeliveryNew England Journal of Medicine, 2020
- Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990–2010: a longitudinal analysisThe Lancet, 2016
- Increase in state suicide rates in the USA during economic recessionThe Lancet, 2012